Leinco Technologies provides an extensive portfolio of high-purity antibodies, recombinant proteins, cytokines, and ELISA development kits specifically engineered for SARS-CoV-2 and coronavirus research. Our products are manufactured at our Missouri facility under ISO 9001:2015 and ISO 13485:2016 standards, offering the consistency required for diagnostic assay development, vaccine research, and therapeutic screening.
Interested in other infectious diseases?
Categories
Filters
Name
Applications
Prod No.
Clone
Availability

